SARS-COV-2 myocarditis. An update
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
The outbreak of the SARS-CoV-2 virus responsible for the COVID-19 disease has given rise to a new disease whose boundaries are still to be discovered. While the first data suggested a purely respiratory infection, the most recent publications highlight a large pleomorphism of the disease, responsible for multiple organ damage, of which cardiac injury seems to be the most represented. This cardiac injury can present as acute myocarditis. Our aim was to discuss the pathophysiological rationale underlying the existence of SARS-CoV-2 myocarditis and to analyze the literature data regarding the diagnosis and treatment of this particular entity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Annales de cardiologie et d'angeiologie - 69(2020), 6 vom: 17. Dez., Seite 349-354 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Myocardite et maladie à COVID-19 : où en est-on ? |
|---|
| Beteiligte Personen: |
Fard, D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Atteinte cardiaque |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 29.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ancard.2020.10.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316388211 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316388211 | ||
| 003 | DE-627 | ||
| 005 | 20240329235821.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.ancard.2020.10.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM316388211 | ||
| 035 | |a (NLM)33069383 | ||
| 035 | |a (PII)S0003-3928(20)30153-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Fard, D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-COV-2 myocarditis. An update |
| 246 | 3 | 3 | |a Myocardite et maladie à COVID-19 : où en est-on ? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a The outbreak of the SARS-CoV-2 virus responsible for the COVID-19 disease has given rise to a new disease whose boundaries are still to be discovered. While the first data suggested a purely respiratory infection, the most recent publications highlight a large pleomorphism of the disease, responsible for multiple organ damage, of which cardiac injury seems to be the most represented. This cardiac injury can present as acute myocarditis. Our aim was to discuss the pathophysiological rationale underlying the existence of SARS-CoV-2 myocarditis and to analyze the literature data regarding the diagnosis and treatment of this particular entity | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Atteinte cardiaque | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Cardiac injury | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Myocardite | |
| 650 | 4 | |a Myocarditis | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Huguet, R |e verfasserin |4 aut | |
| 700 | 1 | |a Koutsoukis, A |e verfasserin |4 aut | |
| 700 | 1 | |a Deguillard, C |e verfasserin |4 aut | |
| 700 | 1 | |a Tuffreau, A-S |e verfasserin |4 aut | |
| 700 | 1 | |a Deux, J-F |e verfasserin |4 aut | |
| 700 | 1 | |a Lim, P |e verfasserin |4 aut | |
| 700 | 1 | |a Teiger, E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales de cardiologie et d'angeiologie |d 1968 |g 69(2020), 6 vom: 17. Dez., Seite 349-354 |w (DE-627)NLM000057096 |x 1768-3181 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2020 |g number:6 |g day:17 |g month:12 |g pages:349-354 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ancard.2020.10.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2020 |e 6 |b 17 |c 12 |h 349-354 | ||